We show here that in addition to lymphocytes, TIM3 is expressed on cells from the myeloid lineage, such as macrophages and stromal cells, which could contribute to more widespread inhibition in the tumor microenvironment [reviewed in Ref. This evidence concerns the gene HAVCR2 and neoplasm.